About Andrew Dahl
Form D filings for BioMEMS Diagnostics in 2023 list Andrew Dahl as executive officer, director and promoter.
Andrew Dahl first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Dahl in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Dahl works with at each company, as listed on that company's latest Form D.
BioMEMS Diagnostics, Inc. · Form D, Jan 17, 2023
MP
Michael Pugia
Executive officer
JO
Jay Offen
Executive officer and director
ZB
Zaine Baird
Executive officer
CF
Casey Fowler
President & CEO, director
JB
John Bohan
Executive officer